Revolution Medicines Inc

Stock Chart, Company Information, and Scan Results

$102.02(as of Feb 27, 4:00 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Revolution Medicines Inc Company Information, Fundamentals, and Technical Indicators

Stock Price$102.02

Ticker SymbolRVMD

ExchangeNasdaq

SectorHealthcare

IndustryBiotechnology

Employees809

CountyUSA

Market Cap$19,722.5M

EBIDTA-1,029.8M

10-Day Moving Average101.72

P/E Ratio-17.15

20-Day Moving Average99.27

Forward P/E Ratio0.00

50-Day Moving Average97.77

Earnings per Share-5.19

200-Day Moving Average60.12

Profit Margin-Infinity%

RSI53.69

Shares Outstanding193.3M

ATR4.28

52-Week High124.49

Volume10,308,300

52-Week Low29.17

Most Recent Support Level95.25

Book Value1,631.3M

Most Recent Resistance Level107.45

Upper Keltner108.91

P/S RatioInfinity

Lower Keltner89.64

Debt-to-Equity Ratio108.91

Next Earnings Date05/11/2026

Cash Surplus93.3M

Next Ex-Dividend DateUnknown

Revolution Medicines, Inc., a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers. The company's research and development pipeline consist of RAS(ON) inhibitors that binds RAS variants to be used as monotherapy in combination with other RAS(ON) inhibitors and/or in combination with RAS companion inhibitors or other therapeutic agents, and RAS companion inhibitors to suppress cooperating targets and pathways that sustain RAS-addicted cancers. Its RAS(ON) inhibitors include daraxonrasib (RMC-6236), elironrasib G12C (RMC-6291), and zoldonrasib G12D (RMC-9805), which are in phase 1 clinical trial; and development candidates comprise RMC-5127 (G12V), RMC-0708 (Q61H), and RMC-8839 (G13C). The company's RAS companion inhibitors include RMC-4630 that is in phase 2 clinical trial; RMC-5552, a selective inhibitor of mTORC1 signaling in tumors, which is in phase 1 clinical trial; and RMC-5845 that targets SOS1. Revolution Medicines, Inc. was incorporated in 2014 and is headquartered in Redwood City, California.

Revolution Medicines Inc In Our Stock Scanner

As of Mar 02, 2026

example chart graphic

Scan Name: Cash SurplusScan Type: Stock Fundamentals

As of ---

example chart graphic

Scan Name: Increasing Book ValueScan Type: Stock Fundamentals

As of ---

example chart graphic

Scan Name: Low Debt to Equity RatioScan Type: Stock Fundamentals

As of ---

example chart graphic

Scan Name: Long Legged DojiScan Type: Candlestick Pattern Scans

As of ---

example chart graphic

Scan Name: Doji CandlesScan Type: Candlestick Pattern Scans

As of ---

example chart graphic

Scan Name: Unusual VolumeScan Type: Stock Indicator Scans

As of ---

example chart graphic

Scan Name: Heikin Ashi BreakoutScan Type: Candlestick Pattern Scans

As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.